Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000368333 | SCV000476023 | uncertain significance | Hypercholanemia, familial | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733513 | SCV000861590 | uncertain significance | not provided | 2018-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000733513 | SCV004510125 | likely benign | not provided | 2024-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004601164 | SCV005096162 | uncertain significance | not specified | 2024-05-07 | criteria provided, single submitter | clinical testing | The c.797T>C (p.I266T) alteration is located in exon 4 (coding exon 3) of the BAAT gene. This alteration results from a T to C substitution at nucleotide position 797, causing the isoleucine (I) at amino acid position 266 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |